Skip to main content
GLPG
NASDAQ Life Sciences

5亿美元现金池，授权150M美元回购用于加拉帕戈斯的Gilead绑定合作

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
9
Price
$28.84
Mkt Cap
$1.923B
52W Low
$22.591
52W High
$37.78
Market data snapshot near publication time

summarizeSummary

加拉帕戈斯和Gilead已经签订了一个绑定协议，以合作推进Ouro Medicines的临床阶段T细胞引发器项目（gamgertamig）用于自身免疫性疾病。这一最终协议是在Gilead以17.75亿美元的前期付款和最高5亿美元的附带里程碑付款收购Ouro Medicines之后签订的。对于加拉帕戈斯来说，这一框架协议提供了显著改善的财务条款，包括5亿美元的现金池用于独立部署和最多150M美元的股票回购授权。这一发展巩固了之前报告的战略合作，即3月23日的“高级讨论”。这一交易为加拉帕戈斯提供了大量的财务灵活性和高潜力的、首创的资产，从而显著推进了其产品线和资本配置策略。对于Gilead来说，这一合作利用其商业能力来加速通过Ouro获得的有前途资产的开发。交易者将会关注进一步关于gamgertamig项目的临床进展以及加拉帕戈斯如何利用其新获得的资本的更新。

在该公告发布时，GLPG的交易价格为$28.84，交易所为NASDAQ，所属行业为Life Sciences，市值约为$19.2亿。 52周交易区间为$22.59至$37.78。 这则新闻被评估为积极市场情绪，重要性评分为9/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed GLPG - Latest Insights

GLPG
Apr 29, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Shareholders Approve Rebranding to Lakefront Biotherapeutics, 10% Share Buyback Authorization, and New Board Chair
Sentiment: Positive
View Wiseek Article
GLPG
Mar 31, 2026, 1:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
$500M Cash Pool, $150M Buyback Authorized for Galapagos in Binding Gilead Collaboration
Sentiment: Positive
View Wiseek Article
GLPG
Mar 30, 2026, 9:41 PM EDT
Filing Type: 6-K
Importance Score:
9
Galapagos Finalizes Binding Agreement with Gilead for Ouro Medicines' T-Cell Engager Program, Gains $500M Strategic Flexibility
Sentiment: Positive
View Wiseek Article
GLPG
Mar 30, 2026, 8:01 AM EDT
Filing Type: 6-K
Importance Score:
8
Galapagos Proposes Rebranding to Lakefront Biotherapeutics, Authorizes Share Buyback, and Appoints New Board Chair
Sentiment: Positive
View Wiseek Article
GLPG
Mar 26, 2026, 4:02 PM EDT
Filing Type: 20-F
Importance Score:
9
Galapagos NV Pivots to New Strategy, Exits Cell Therapy, Proposes Name Change to Lakefront Biotherapeutics
Sentiment: Neutral
View Wiseek Article
GLPG
Mar 23, 2026, 6:58 PM EDT
Filing Type: 6-K
Importance Score:
8
Galapagos & Gilead Detail Strategic Collaboration for Autoimmune T-Cell Engager; Galapagos to Fund Half of $1.675B Acquisition & Gain $500M Cash Flexibility
Sentiment: Positive
View Wiseek Article
GLPG
Mar 23, 2026, 6:25 PM EDT
Source: GlobeNewswire
Importance Score:
9
Galapagos to Fund Half of Gilead's $1.675B Ouro Acquisition for Autoimmune Drug Collaboration, Gains $500M Cash Flexibility
Sentiment: Positive
View Wiseek Article
GLPG
Mar 17, 2026, 5:26 PM EDT
Filing Type: 6-K
Importance Score:
7
Bank of America Reduces Stake in Galapagos Below 5% Threshold
Sentiment: Negative
View Wiseek Article
GLPG
Mar 06, 2026, 4:28 PM EST
Filing Type: 6-K
Importance Score:
7
Galapagos Board Approves New Employee Subscription Right Plan for 1.75 Million Shares
Sentiment: Neutral
View Wiseek Article
GLPG
Mar 05, 2026, 4:28 PM EST
Filing Type: 6-K
Importance Score:
7
Galapagos Appoints Tania Philipp as New CHRO to Drive Culture Transformation
Sentiment: Positive
View Wiseek Article